tiprankstipranks
Rigel Pharmaceuticals’ Strategic Resolutions at 2024 Annual Meeting
PremiumCompany AnnouncementsRigel Pharmaceuticals’ Strategic Resolutions at 2024 Annual Meeting
2M ago
Rigel Pharmaceuticals announces presentations at upcoming ASCO
PremiumThe Fly
Rigel Pharmaceuticals announces presentations at upcoming ASCO
2M ago
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
Rigel Pharmaceuticals price target raised to $4 from $3 at Citi
PremiumThe FlyRigel Pharmaceuticals price target raised to $4 from $3 at Citi
4M ago
New Corporate Activity and Growth Risk for Rigel Pharmaceuticals – What’s the Latest?
PremiumCompany Announcements
New Corporate Activity and Growth Risk for Rigel Pharmaceuticals – What’s the Latest?
4M ago
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4M ago
Rigel Pharmaceuticals price target raised to $1.75 from $1.25 at B. Riley
PremiumThe FlyRigel Pharmaceuticals price target raised to $1.75 from $1.25 at B. Riley
5M ago
Rigel Pharmaceuticals Expands Oncology Portfolio with Blueprint Deal
PremiumCompany Announcements
Rigel Pharmaceuticals Expands Oncology Portfolio with Blueprint Deal
5M ago
Rigel Pharmaceuticals acquires U.S. rights to Gavreto
PremiumThe Fly
Rigel Pharmaceuticals acquires U.S. rights to Gavreto
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100